Breaking bad news to patients

Breaking bad news is always a complex and sensitive task that requires practice and a considerate, tactful approach.

In addition to the verbal component of providing medical information, it also requires other skills such as responding to patients’ emotional reactions, involving them in decision-making, dealing with the stress created by expectations for a cure, the involvement of multiple family members, and the dilemma of how to give hope when the situation is bleak.

When healthcare professionals lack proper training in communication skills, delivering bad news can lead to negative consequences for the individuals receiving the news. For example, poor communication with cancer patients has been shown to be associated with worse clinical and psycho-social outcomes, including worse pain control, worse adherence to treatment, and confusion over prognosis, etc.

For this reason, in the last Monthly Pulse question we asked the M3 Global Research community:

"As a healthcare professional, do you feel prepared enough to deliver bad news to patients?"

From the healthcare professionals surveyed, the majority said they felt prepared to deliver bad news to patients. Spain, Italy and UK had very similar results with between 64% – 78% stating “YES“. France, instead, was divided, with 50%.

Breaking bad news

Even in a wider Cross-Continental analysis between Europe, Brazil and Canada, the majority said of the healthcare professional surveys stated to felt prepared to deliver bad news to patients. Results are very similar, 68%, 71% and 74% respectively.

Breaking bad news

By signing up to M3 Global Research, you will be able to take part in paid medical surveys tailored to you area of expertise and you will also receive the Monthly Pulse directly to your inbox. You will be able to answer one question about relevant hot topic in healthcare and compare your opinion with colleagues from all over the world.

Leave a Reply

Join Today

Registration is free and only takes a few clicks

Panel Members

Check your available studies

latest posts

emerging respiratory treatments for lung cancer - cystic fibrosis - robotic navigation - gene-editing nanoparticles

Emerging Respiratory Treatments: Frontiers in Pulmonology

Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.

Paid Studies About Medical Devices | M3 Guide

Real-World Evidence studies collect real-world data to evaluate the safety and performance of medical devices. This M3 Guide reveals how we conduct Real-World Evidence studies, how they contribute to better patient outcomes, and how healthcare professionals can get compensated.